This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Medicare's Coverage With Evidence Development: A Policy-Making Tool in Evolution

Coverage with evidence development is a tool used by the Centers for Medicare & Medicaid Services (CMS) in an attempt to bring a new rationale to payment decisions and, ultimately, cost savings to the Medicare program. Here we explore the latest evolution in Medicare coverage policy and coverage with evidence development (CED), discussing how it developed and what it means for practicing oncologists.

	Origins of CED

 
Evidence-based medicine (EBM), making treatment decisions on the basis of previous examples of effectiveness or ineffectiveness, is the foundation for identifying gaps in evidence and for evaluating existing evidence to establish best practices.¹ With the variety of . . . [Click for More]